Publications

The anti-obesity drug revolution: a booming market

Article published in allnews on October 4, 2024

“Innovation is the key to success for pharmaceutical companies, whose leadership position can waver at any moment.”

At a time when obesity has become a global priority, pharmaceutical companies are racing to develop innovative solutions. Leaders such as Eli Lilly and Novo Nordisk currently dominate, but competition is intensifying and new molecules could change the game.

Read the commentary by Stéphanie Rheinboldt, Senior Equity Advisor, published in Allnews on October 4, 2024, in French : La course aux médicaments anti-obésité | Allnews

October 04, 2024

Publications

Third Pillar: Between Tax Opportunities and Uncertainty Over Taxation

From 1st January 2025, a major reform of the third pillar has come into effect, introducing the possibility of making retroactive buy-ins.

March 06, 2025

Publications

Europe at a Crossroads

In his latest article published in Allnews, Jean-Christophe Rochat analyses the key dynamics at play and the challenges ahead

February 19, 2025

Publications

The tokenization of financial assets: a revolution in the making?

In her latest article for Allnews, Stéphanie Rheinboldt, Senior Equity Advisor, explores the opportunities and prospects offered by the tokenisation of financial assets.

February 13, 2025